Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Plenary session at ASCO 2020

Melissa Johnson • 27 May 2020
ASCO 2020
Bladder Cancer Breast Cancer Colorectal Cancer Genitourinary Cancer
ADAURA

Melissa Johnson, MD, Sarah Cannon Research Institute, Nashville, TN, talks through the abstracts presented during the plenary session at ASCO 2020. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Melissa Johnson

1:49
ADCs for lung cancer
Melissa Johnson • 27 Feb 2023
1:30
Cellular therapies for NSCLC
Melissa Johnson • 27 Feb 2023
3:46
Targeting IL-2 in advanced NSCLC
Melissa Johnson • 27 Feb 2023
2:42
CodeBreaK 200: sotorasib versus docetaxel in pretreated KRAS G12C-mutant NSCLC
Melissa Johnson • 15 Sep 2022

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals